Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2163182 Target Snapshot

NAD-dependent protein deacylase sirtuin-6 · SINGLE PROTEIN · Homo sapiens

446Compounds
194Assays
2Approved Drugs
204.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q8N6T7. Use UniProt Q8N6T7 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q8N6T7 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats NAD-dependent protein deacylase sirtuin-6 as ChEMBL target CHEMBL2163182, mapped to UniProt Q8N6T7. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
NAD-dependent protein deacylase sirtuin-6
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL2163182
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q8N6T7
NAD-dependent protein deacylase sirtuin-6
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether NAD-dependent protein deacylase sirtuin-6 is the right protein anchor across sources, using UniProt Q8N6T7 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelNAD-dependent protein deacylase sirtuin-6
UniProt AccessionQ8N6T7
Component TypeProtein
Sequence Length355 aa

NAD-dependent protein deacylase sirtuin-6

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as NAD-dependent protein deacylase sirtuin-6, mapped to UniProt Q8N6T7. Sequence length is 355 aa.

Mapped IDQ8N6T7
Review nameNAD-dependent protein deacylase sirtuin-6
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
1
Phase III
3
Phase II
2
Phase I
Assay Mix

Activity Type Distribution

IC50143.0
KI5.0
EC5047.0
KD9.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4438193 6.6 IC50 250.0 Preclinical
CHEMBL5277251 6.59 IC50 256.0 Preclinical
CHEMBL5274589 6.55 IC50 282.0 Preclinical
CHEMBL5281352 6.5 IC50 319.0 Preclinical
CHEMBL5267327 6.5 IC50 319.0 Preclinical
CHEMBL5280037 6.43 IC50 368.0 Preclinical
CHEMBL5270531 6.3 IC50 495.0 Preclinical
CHEMBL4645806 5.77 IC50 1700.0 Preclinical
CHEMBL151 5.72 IC50 1900.0 Clinical
CHEMBL50 5.72 IC50 1900.0 Clinical
Distribution

pChEMBL Value Distribution

25
5.0
12
5.5
2
6.0
6
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

194
Total Assays
96
Tested Compounds
2
Assay Types
Binding — 192 assays, 96 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 108 77 4.9
cell-based format 46 1 5.2
assay format 38 18 5.0
Functional — 2 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
organism-based format 2 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine